Filing Flows › ResMed (RMD) › Q1 FY27
ResMed (RMD) Q1 FY27 earnings results (first quarter fiscal 2027)
10-Q filed Oct 30, 2026
ResMed (RMD) reported revenue of $1.4B for the first quarter fiscal 2027 (Q1 FY27), +6% from a year earlier and -3% from the quarter before. Operating margin was 32.0%, net earnings $418M (29.6% of revenue).
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart follows the revenue to costs, profit and cash.
| Q1 FY27 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.4B | -3% | +6% |
| Gross profit | $871M | +1% | +6% |
| Operating profit | $453M | +1% | +1% |
| Net earnings | $418M | +9% | +20% |
| Operating cash flow | $422M | -7% | -8% |
| Free cash flow | $374M | -7% | -10% |
What changed
Revenue was $1.4B in Q1 FY27, up 6% year over year and down 3% from the previous quarter. Total Sleep and Breathing Health was the largest line at 89% of revenue. Total Sleep and Breathing Health added $0.09B year over year (up 8%), 114% of the total change. Residential Care Software declined 7%.
Gross margin was 61.5%, up 0.3 points from Q1 FY26. Operating profit was $0.45B, a 32.0% margin (down 1.4 points year over year). Of the extra revenue versus Q1 FY26, 8% reached operating profit, below the 33% margin then. Operating expenses grew 13% against revenue growth of 6%. The fastest-growing cost line was Research & development (+15%). Net earnings were $0.42B, up 20% year over year. The effective tax rate was 22.4%.
Operating cash flow was $0.42B (down 8% year over year), 101% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.03B of share-based compensation. Working capital and other items used $0.07B. Capital expenditures of $0.05B left free cash flow of $0.37B.
Questions
What was ResMed's revenue in the first quarter fiscal 2027?
ResMed (RMD) reported revenue of $1.4B for the first quarter fiscal 2027 (Q1 FY27), +6% from a year earlier and -3% from the quarter before.
Was ResMed profitable in the first quarter fiscal 2027?
Operating profit was $453M (32.0% of revenue) and net earnings $418M.
Source: ResMed 10-Q on SEC EDGAR.